Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Collplant Biotechnologies stock
Learn how to easily invest in Collplant Biotechnologies stock.
Collplant Biotechnologies Ltd is a biotechnology business based in the US. Collplant Biotechnologies shares (CLGN) are listed on the NASDAQ and all prices are listed in US Dollars. Collplant Biotechnologies employs 66 staff and has a trailing 12-month revenue of around $582,000.
How to buy shares in Collplant Biotechnologies
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CLGN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Collplant Biotechnologies stock price (NASDAQ: CLGN)Use our graph to track the performance of CLGN stocks over time.
Collplant Biotechnologies shares at a glance
|Latest market close||$6.30|
|52-week range||$6.51 - $23.00|
|50-day moving average||$8.22|
|200-day moving average||$9.95|
|Wall St. target price||$17.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.30|
Buy Collplant Biotechnologies shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Collplant Biotechnologies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Collplant Biotechnologies price performance over time
|1 week (2022-09-21)||-21.64%|
|1 month (2022-08-26)||-21.25%|
|3 months (2022-06-28)||-21.40%|
|6 months (2022-03-28)||-47.06%|
|1 year (2021-09-28)||-63.16%|
|2 years (2020-09-28)||-24.01%|
|3 years (2019-09-26)||57.11%|
|5 years (2017-09-24)||N/A|
Collplant Biotechnologies financials
|Gross profit TTM||$13.6 million|
|Return on assets TTM||-18.67%|
|Return on equity TTM||-33.72%|
|Market capitalisation||$78.2 million|
TTM: trailing 12 months
Collplant Biotechnologies share dividends
We're not expecting Collplant Biotechnologies to pay a dividend over the next 12 months.
Have Collplant Biotechnologies's shares ever split?
Collplant Biotechnologies's shares were split on a 2:3 basis on 20 November 2016. So if you had owned 3 shares the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Collplant Biotechnologies shares – just the quantity. However, indirectly, the new 50% higher share price could have impacted the market appetite for Collplant Biotechnologies shares which in turn could have impacted Collplant Biotechnologies's share price.
Collplant Biotechnologies share price volatility
Over the last 12 months, Collplant Biotechnologies's shares have ranged in value from as little as $6.51 up to $23. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Collplant Biotechnologies's is 1.0979. This would suggest that Collplant Biotechnologies's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Collplant Biotechnologies overview
CollPlant Biotechnologies Ltd. , a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd.
Collplant Biotechnologies in the news
Use of Collagen and HA-based Biomaterials to Be Prominent in Joint Reconstructive Surgeries: Fact.MR Report
Frequently asked questionsWhat percentage of Collplant Biotechnologies is owned by insiders or institutions?
Currently 10.16% of Collplant Biotechnologies shares are held by insiders and 12.234% by institutions. How many people work for Collplant Biotechnologies?
Latest data suggests 66 work at Collplant Biotechnologies. When does the fiscal year end for Collplant Biotechnologies?
Collplant Biotechnologies's fiscal year ends in December. Where is Collplant Biotechnologies based?
Collplant Biotechnologies's address is: Weizmann Science Park, Rehovot, Israel, 7670104 What is Collplant Biotechnologies's ISIN number?
Collplant Biotechnologies's international securities identification number is: IL0004960188 What is Collplant Biotechnologies's CUSIP number?
Collplant Biotechnologies's Committee on Uniform Securities Identification Procedures number is: 19516Q208
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert